Nourishing Your Body on a GLP-1: The Essential Role of Nutrition & Behaviour Management

Why What You Eat Matters More Than Ever on a GLP-1

If you have tuned into health news over the last couple of years, you have undoubtedly heard of medications like Ozempic, Wegovy, and Mounjaro. These treatments have completely reshaped the landscape of modern metabolic medicine and chronic weight management.  

At the centre of this revolution is a single, hard working gut hormone: GLP-1 (Glucagon-Like Peptide-1).

While these medications are incredibly powerful tools, they are not meant to do the work alone. In fact, clinical data shows that what you eat while taking a GLP-1 is just as important as the medication itself. Here is a breakdown of how GLP-1 works in your body, why it causes certain side effects, and how a nutritional therapist can help you maximise your health outcomes.

What is GLP-1 and How Does It Work?

GLP-1 is a hormone naturally produced by your intestines. Every time you eat, your gut releases it to act as a chemical messenger between your digestive tract and your brain, sending a clear signal that nourishment has arrived.  

According to comprehensive reviews on metabolic health, GLP-1 manages your blood sugar and your appetite by targeting three key areas simultaneously:  

• The Pancreas: It prompts the beta cells in your pancreas to release insulin when your blood sugar rises. Crucially, this response is glucose-dependent, meaning it stops as soon as your blood sugar drops back to normal, preventing dangerous dips in blood sugar

• The Stomach: It slows down gastric emptying, meaning food physically stays in your stomach for longer. This prolonged digestion keeps you feeling satisfied for hours after a meal.  

• The Brain: It binds directly to receptors in the hypothalamus (the brain’s appetite control centre). This turns down your hunger signals and effectively silences "food noise", the constant, intrusive thoughts about food.

Why We Need "Agonists"

Your body's natural GLP-1 is incredibly short-lived; enzymes in your blood destroy it within a couple of minutes. Medications like semaglutide (Ozempic/Wegovy) or tirzepatide (*Mounjaro/Zepbound) are known as GLP-1 receptor agonists. Scientists engineered them to resist these enzymes, allowing the hormone's biological effects to last for a full week in your body.  

Navigating the Side Effects

Because GLP-1 therapies dramatically alter how fast food passes through your system, your gastrointestinal tract has to go through a major adaptation period. This can result in common, mild-to-moderate side effects:  

• Nausea and vomiting  

• Diarrhea or constipation  

• Acid reflux and bloating  

These symptoms are a direct byproduct of the slowed digestion process, but they can often be modified and reduced through targeted nutritional strategies.

Why a Nutritional Therapist is Vital to Your GLP-1 Journey

Prescribing these medications is a medical job, but navigating the daily reality of eating on them is a nutritional one. As a nutritional therapist, my role is to act as your strategy partner, helping you manage the biological shifts taking place in your body.

A joint clinical advisory published by the American College of Lifestyle Medicine and The Obesity Society outlines several key reasons why structured nutritional support is essential while on a GLP-1:  

1. Preserving Lean Muscle Mass

When you lose weight rapidly on a GLP-1, you don't just lose fat tissue; you are also at risk of losing skeletal muscle. Data shows that without proper intervention, lean mass can account for a significant portion of total weight reduction.  

• The Strategy: I help you establish a targeted daily protein intake and map out specific, high-quality, nutrient-dense protein sources to protect your lean tissue and keep your metabolism strong.

2. Managing GI Side Effects Naturally

You don't have to simply "endure" nausea or reflux. Many side effects stem from eating too quickly or consuming foods that put excess mechanical stress on a slowed stomach.

• The Strategy: We implement structural habits, like eating smaller, frequent meals, modifying fibre textures during symptom flare-ups, and building strict hydration protocols to ease constipation and combat the blunted thirst cues caused by the medication.

3. Preventing Nutrient Deficiencies

Because GLP-1s lower your overall food intake by 16% to 39%, your total volume of food drops drastically. When you eat less food, you naturally take in fewer vitamins and minerals, putting you at risk for micronutrient deficiencies.  

• The Strategy: We ensure that every bite counts by focusing on food first nutrition, identifying sneaky gaps in your daily intake, and selecting targeted supplements if necessary to prevent fatigue, hair thinning, or muscle weakness.

4. Creating a Sustainable Exit Strategy

Obesity and metabolic dysfunction are chronic conditions. Real-world database tracking shows that over half of individuals discontinue GLP-1 therapy within the first year, often due to cost, supply issues, or side effects. However, stopping the medication without changing your underlying habits often triggers rapid weight regain.  

• The Strategy: The medication quiets the food noise, but it cannot teach you how to build a balanced plate. We use the time you are on the medication to rewrite your relationship with food, map out behaviour shifts, and establish solid lifestyle habits. If you ever choose to titrate off under your doctor's supervision, we will have a comprehensive dietary blueprint ready to support your long-term success.

The Bottom Line

Prescribing a GLP-1 is only one piece of the puzzle. To truly optimise your health, prevent muscle loss, and ensure the changes you make last a lifetime, personalised nutritional and behavioural change support is key.  

Want to chat about designing a nutritional plan tailored to your lifestyle?

*Note: Mounjaro is a "dual agonist." In addition to mimicking GLP-1, it also mimics a second gut hormone called GIP (Gastric Inhibitory Polypeptide - GIP), which further enhances weight loss and blood sugar stability.

American College of Lifestyle Medicine, & The Obesity Society. (2025). Nutritional priorities to support GLP-1 receptor agonist therapy for obesity: A joint consensus statement. Lifestyle Medicine Advisors. https://www.obesity.org/nutritional-priorities-to-support-glp-1-therapy-for-obesity/

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022). Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations. Drug Design, Development and Therapy, 16, 4449–4461. https://doi.org/10.2147/DDDT.S365416

European Congress on Obesity. (2026, May). Changes in body composition and skeletal muscle index during long-term anti-obesity medications: Real-world cohort analysis. ECO 2026 Annual Meeting, Abstract Presentation. https://www.news-medical.net/news/20260513/GLP-1-obesity-drugs-mainly-reduce-fat-while-preserving-muscle-mass.aspx

Rosen, C. J. (2026). GLP-1 receptor agonists. New England Journal of Medicine, 394(13), 1313–1324. https://pubmed.ncbi.nlm.nih.gov/34192449/